Blog | Veristat Insightful Perspectives

Veristat Raises >$350K For Rare Cancer Research

Team Veristat Participate in Cycle for Survival 2021 - Virtually

 

For the past seven years, Veristat has participated in Memorial Sloan Kettering's Cycle for Survival, the movement to beat rare cancers. Founded in partnership with Equinox fitness club back in 2006, this ground-breaking research fundraiser celebrated its 15th anniversary in 2021 and has raised nearly three hundred million dollars for rare cancer research to date.

Read More

Beating Rare Cancers Requires Your Help - JOIN THE BATTLE TODAY!

As a scientifically oriented and impactful full-service clinical research organization (CRO) that is committed to partnering with pharmaceutical, biotechnology, and medical device firms to advance their therapies throughout the entire clinical development and regulatory submission process,  Veristat works each day with a focus on improving the lives of patients with rare cancers

Read More

Flexibility is the Key to Data Acquisition for Rare Disease Trials

Understanding Why Creative Data Collection Solutions Are Necessary

Read More

Competing Risk Analysis in Clinical Trials | A Practical Example

In pharmaceutical clinical trials, considering competing risk analyses is highly important. Competing risks are events that may occur and prevent the evaluation of a specific primary endpoint, in turn biasing risk estimations or drug efficacy. 

Read More